Mineralocorticoid receptor antagonists reduce risk of cardiovascular events in patients with heart failure Post author: Post published:September 3, 2024 Post category:uncategorized MRAs significantly lower the risk of cardiovascular death and HF hospitalization in heart failure patients. You Might Also Like Major study launched to explore diet and exercise benefits for metastatic breast cancer patients October 10, 2024 Advances in bladder cancer treatments offer hope for curative care November 14, 2024 Orthopedic encounters could play key role in early detection of intimate partner violence January 5, 2026
Major study launched to explore diet and exercise benefits for metastatic breast cancer patients October 10, 2024
Orthopedic encounters could play key role in early detection of intimate partner violence January 5, 2026